If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2006-2014 Ph.D., Graduate Institute of clinical medicine, Taipei Medical University
  • 1984-1991 M.D., School of Medicine, College of Medicine, Taipei Medical College

Experience

  • Director, Division of Gastroenterology, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
  • Attending Physician, Division of Gastroenterology, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
  • 2019.08- Director, Division of Gastroenterology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
  • 2017.08- Assistant Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University 
  • 2015.06- Assistant professor, Department of Gastroenterology, School of Medicine, Taipei Medical University

Awards

  • 2008 World Congress of Internal Medicine, Silver Medal Reward of International Campaign of Evidence-Based Medicine

Research Interests

  • Radiofrequency ablation of hepatocellular carcinoma
  • Cellular stress response of colon cancer cells

Fingerprint Dive into the research topics where Ming-Shun Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 546 Citations
  • 13 h-Index
  • 41 Article
  • 1 Comment/debate

Activation of PERK contributes to apoptosis and G2/M arrest by microtubule disruptors in human colorectal carcinoma cells

Wu, M. S., Chien, C. C., Jargalsaikhan, G., Ilsan, N. A. & Chen, Y. C., Jan 2020, In : Cancers. 12, 1, 97.

Research output: Contribution to journalArticle

Open Access
  • Clinical evaluation of CA72-4 for screening gastric cancer in a healthy population: A multicenter retrospective study

    Hu, P. J., Chen, M. Y., Wu, M. S., Lin, Y. C., Shih, P. H., Lai, C. H. & Lin, H. J., May 2019, In : Cancers. 11, 5, 733.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Citations (Scopus)
    Open Access
  • 2 Citations (Scopus)

    Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform

    Lin, H. S., Huang, Y. L., Wang, Y. R., Hsiao, E., Hsu, T. A., Shiao, H. Y., Jiaang, W. T., Sampurna, B. P., Lin, K. H., Wu, M. S., Lai, G. M. & Yuh, C. H., Jun 1 2019, In : Cancers. 11, 6, 739.

    Research output: Contribution to journalArticle

    Open Access
  • 11 Citations (Scopus)
    Open Access
  • 6 Citations (Scopus)